ML-016 for neoplasm metastasis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 23 Jul 2026: Trial registered, NCT07723482
  2. 25 Sep 2026: Trial started, NCT07723482

The trials

NCT07723482: ML-016 in Advanced Cancer With Lung and/or Liver Involvement

State
Under way
Phase
Phase 1 and Phase 2
People
108 planned
Started
25 Sep 2026
Primary completion
Oct 2027
Arms
ML-016 Monotherapy
Results
None posted
  1. 23 Jul 2026: Trial registered
  2. 25 Sep 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.